Insider Transactions in Q3 2021 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2021
|
Derek T Chalmers President & CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.98%
|
$300,000
$15.47 P/Share
|
|
Aug 30
2021
|
Derek T Chalmers President & CEO |
SELL
Open market or private sale
|
Direct |
8,440
-0.83%
|
$118,160
$14.2 P/Share
|
|
Aug 30
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,110
-4.22%
|
$29,540
$14.2 P/Share
|
|
Aug 30
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
3,847
-2.65%
|
$53,858
$14.2 P/Share
|
|
Aug 30
2021
|
Thomas Charles Reilly Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,982
-37.16%
|
$27,748
$14.2 P/Share
|
|
Aug 30
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
1,759
-2.42%
|
$24,626
$14.2 P/Share
|
|
Aug 24
2021
|
Derek T Chalmers President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,334
+1.67%
|
-
|
|
Aug 24
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
9,600
+6.21%
|
-
|
|
Aug 24
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,400
+11.35%
|
-
|
|
Aug 24
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
5,334
+6.84%
|
-
|
|
Aug 24
2021
|
Thomas Charles Reilly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,334
+50.0%
|
-
|